Pressmeddelande -

Global Attention Calls for International Investment Information

As a result of its patented diabetes device having reached more widespread attention earlier than anticipated, Brighter is releasing a summary of the company’s investment information in English. This information is to accommodate international investors interested in the Swedish medtech company based in Stockholm.

The investment information enables companies and individuals in many parts of the world to become shareholders in Brighter during its initial public offering (IPO) that is open until September 26, 2011.

Other selected company information can also be found translated into English at the company’s website: www.BrighterCompany.com/english

Due to the regulations of respective countries, if you reside in the USA, Canada, Australia, Japan or New Zealand you may NOT take part in this investment offer.


Five Good Reasons to Invest in Brighter

  • 75 per cent of all insulin-treated diabetics want an integrated device for self-care. No player has so far offered diabetics such an all-in-one solution.
  • Brighter has developed and patented the world’s first all-in-one self-care solution for diabetics that does not need to be attached to the body. The primary target group for this product series, Brighter One™, consists of 14 million diabetics in Europe and USA – a market with an annual turnover of approximately 25 billion SEK and that grows by 5-10% per year.
  • The critical technical components are licensed in and already included in both FDA-approved and CE-marked products. Brighter has attained a technical “proof of concept” and carried out a detailed cost assessment for parts and production.
  • Brighter is ready for production adaption and with the on-going IPO, the production of the manufacturing line is assured.
  • Sales channels are ready for the Scandinavian markets thanks to cooperation with Rubin Medical – one of the largest distributors of diabetes devices in the Scandinavian markets as well as for the last two years twice appointed Gazelle company by Dagens Industri, Sweden’s leading daily financial newspaper.


The Offer in Summary

Rights Issue: Private placement to present shareholders and to the public

IPO issue price: SEK 3.20 per share

Minimum purchase: 1 000 shares

IPO period: August 15 – September 26, 2011

Amount of shares issued: 2 656 000

Gross issue size: MSEK 8.5

"Pre-money" valuation of the company: MSEK 32




About Brighter AB (publ)

Brighter develops and commercializes innovative solutions for diabetes self-care. It is a STING Alumni company. Financing has come from governmental and institutional investors such as ALMI, Innovationsbron, KAS Innovationsfond (a Bonnier family foundation) as well as from private investors.

During the period August 15 to September 26, there is a unique opportunity to buy shares in Brighter. After the introduction issuing, Brighter will be listed at AktieTorget. For more information: www.BrighterCompany.com.


Contact Information

http://www.BrighterCompany.com

http://www.BrighterCompany.com/video

http://www.facebook.com/brightercompany

http://twitter.com/Brighter_AB


Phone: +46 8 55 00 88 20

Fax: +46 8 55 00 88 30


Truls Sjöstedt, CEO at Brighter AB (publ)

Phone: +46 709 73 46 00

E-mail: truls.sjostedt@brightercompany.com

Relaterade länkar

Ämnen

  • Företagande

Kategorier

  • aktiehandel
  • aktietorget
  • brighter
  • diabetes
  • diabetesvård
  • diabetiker
  • emission
  • ipo
  • listning
  • medtech
  • nyemission
  • shares
  • issue of shares


Kontakter

Relaterad media

Relaterat innehåll

  • Massive Demand – Extended IPO Period

    As the opportunity to issue shares and receive presentations of Brighter One™ has by far surpassed the expectations, the board of Brighter chooses to extend the IPO period until September 26.

  • Ny video från Medtech Investment Day Scandinavia 2011

    Brighter publicerar en ny presentationsvideo för potentiella investerare från Medtech Investment Day Scandinavia 2011. Videon finns att se på YouTube under följande adress: http://bit.ly/Medtech

  • Brighter Sheds Light on the Darkness of the Stock Markets

    In the middle of one of the darkest periods on the stock markets, medtech company Brighter AB (publ) invites to its IPO at AktieTorget with the purpose to attract 8.5 MSEK. With the main patent approved a year earlier than planned, Brighter leaves the development period and goes on to commercializing the product portfolio Brighter One TM, an attractive world news with great global potential.

  • Brighter Has Launched Its Initial Public Offering Period

    Brighter AB (publ) has launched its Initial Public Offering period at AktieTorget as promised. The company has developed and patented the world’s first all-in-one self-care device for diabetics that does not need to be attached to the body. Now, the public is offered a unique opportunity to take part in Brighter’s future growth through the IPO.

Fyll i din epostadress för att följa Brighter AB (publ)

När du väljer att skapa ett konto och följa ett nyhetsrum kommer dina personuppgifter behandlas av oss och av ägaren av nyhetsrummet för att du ska kunna motta nyheter och uppdateringar enligt dina bevakningsinställningar.

För att läsa mer om detta, var vänlig läs vår Integritetspolicy som berör vår behandling av dina personuppgifter, och Integritetspolicy för Contacts som berör behandlingen av dina personuppgifter från ägaren av nyhetsrummet du följer.

Vänligen notera att våra Användarvillkor gäller alla våra tjänster.

Du kan dra tillbaka ditt samtycke när som helst genom att avregistrera dig eller genom att ta bort ditt konto.
Kolla din inkorg

Mejl skickat till __email__. Klicka på länken i mejlet för att följa Brighter AB (publ).

Okej